Vol. 8 No. 2 (2016)

Artigos

• Hospital administration in Portugal: relationship between seniority and employee involvement, and implications for turnover risk

  Pedro Miguel Correia, Pedro Miguel Carrapato, João Bilhim

  73-79

  • PDF (Português (Brasil))

• Diabetes Mellitus in Brazil: clinical characteristics, standard treatment choice and cost

  José Francisco Saraiva, Miguel Hissa, João Felício, Catarina Cavalcanti, Gabriela Saraiva, Tony Piha, Antônio Roberto Chacra

  80-90

  • PDF (Português (Brasil))

• Impact of the non-small cell lung cancer in Brazil

  Cristina Ferreira, Vivian Blunk, Carlos Felipe Santana, Haline Squiassi

  91-98

  • PDF (Português (Brasil))

• Anxiolytics and antidepressants drugs dispensed in Primary Care: cost analysis and drug interactions

  Clayre Anne Aguiar, Felipe Macedo, Ana Paula Abdon, Adriana Campos

  99-107

  • PDF (Português (Brasil))

• Health Production Function for the Rio Grande do Sul in 2008

  Cristiane Silva, Anderson Santos, Giácomo Balbinotto Neto

  108-117

  • PDF (Português (Brasil))

• Study of costs of admissions for ischemic heart disease in individuals with and without diabetes mellitus in cardiac reference center brazilian Unified Health System

  Márcia Gisele Costa, Marisa Santos, Monica Cintra, Marcelo Correia

  118-124

  • PDF (Português (Brasil))

• Percent economic analysis of acquired drugs purchases through lawsuits

  Vitória Picolini, José Fernando Alvarenga, Juliana Fila, Patrícia Mastroianni

  125-131

  • PDF (Português (Brasil))

• Cost-effectiveness of n-buthyl-cyanoacrylate for mesh fixation in inguinal hernioplasty under the perspective of Supplementary Healthcare in Brazil

  Luciana Mensor, Regina Contadin, Camila Pepe, Elisanio Cardoso

  132-140

  • PDF (Português (Brasil))

• Number needed to treat (NNT) and cost of preventing an event (COPE) of enzalutamide vs. abiraterone acetate plus prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) patients who failed androgen deprivation therapy (A

  Stephen Stefani, André Sasse, André Fay, Hellen Kim, Marcia Abadi, Vanessa Teich, Gilberto Lopes

  141-148

  • PDF (Português (Brasil))

• Costs and treatment patterns in patients with advanced non-small cell lung cancer in the private health system

  Straus Tanaka, Thiago Chadid, Graziela Bernardino

  149-154

  • PDF (Português (Brasil))

• Cost per responder analysis of biologic drugs for the treatment of moderate to severe psoriasis under Brazilian public and private healthcare systems perspectives

  Luciana Scaccabarozzi, Cintia Rey, Hellen Kim, Laura Amaral, Roberta Fernandes, Elio Asano, Isabel Genov

  155-163

  • PDF (Português (Brasil))

• Cosmetic treatment with OnabotulinumtoxinA (Botox®): relationship between initial clinical assessment, dosage and costs

  Raphael Chu, Fábio Saito, Thiago Biasi

  164-171

  • PDF (Português (Brasil))